| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |
| 02/05/2008 | CA2402686C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 02/05/2008 | CA2349227C Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 02/05/2008 | CA2281642C Substituted 2,4-diaminopyrimidines |
| 02/05/2008 | CA2264065C Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 02/05/2008 | CA2205406C Novel benzyl pyrimidines |
| 01/31/2008 | WO2008014381A2 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | WO2008014361A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | WO2008014360A2 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | WO2008014252A2 Iap inhibitors |
| 01/31/2008 | WO2008014249A2 Improved preparations of 2 -substituted pyrrolo [2, 3-b] pyrazine ( 4, 7 -diazaindole ) compounds |
| 01/31/2008 | WO2008014236A1 Dimeric iap inhibitors |
| 01/31/2008 | WO2008013840A2 Erastin analogs and uses thereof |
| 01/31/2008 | WO2008013823A2 Co-crystals of (2r-trans)-6-chloro-5-[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n,1-trimethyl-alpha-oxo-1h-indole-3-acetamide |
| 01/31/2008 | WO2008012852A1 Intermediate compounds for the preparation of angiotensin ii antagonists |
| 01/31/2008 | WO2008012524A1 Substituted aniline derivatives |
| 01/31/2008 | WO2008012441A2 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 01/31/2008 | WO2008012372A1 Process for the preparation of candesartan cilexetil form i |
| 01/31/2008 | WO2008012371A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography |
| 01/31/2008 | WO2008012326A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/31/2008 | WO2007127448A3 Salts of pyridazine compounds |
| 01/31/2008 | WO2007098507A3 Compositions and methods for inhibition of the jak pathway |
| 01/31/2008 | US20080027231 High stability diionic liquid salts |
| 01/31/2008 | US20080027226 Electroluminescent Device |
| 01/31/2008 | US20080027211 Enantiopure Heterocyclic Compound Useful for the Preparation of Peptides Which Can Be Potentially Used as Medicaments |
| 01/31/2008 | US20080027117 Antifungal Azole Derivatives Having a Fluorovinyl Moiety and Process for the Preparation Thereof |
| 01/31/2008 | US20080027100 Functionally selective alpha2C adrenoreceptor agonists |
| 01/31/2008 | US20080027093 Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 01/31/2008 | US20080027092 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders |
| 01/31/2008 | US20080027076 Pyrimidines With Tie2 (Tek) Activity |
| 01/31/2008 | US20080027074 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole; 3-(2-piperazin-1-yl-phenylsulfanyl)-1H-indole-7-carboxylic acid methyl ester; attention deficit hyperactivity disorder (ADHD); serotonin, norepinephrine and/or dopamine reuptake inhibitors reuptake inhibitors |
| 01/31/2008 | US20080027071 2-{2-[4-(2,3-Dihydrobenzo[1,4]dioxin-5-yl)piperazin-1-yl]ethylsulfanyl}-6-methylnicotinonitrile; serotonin and dopamine receptor antagonist, serotonin reuptake inhibitor; anxiolytic agent, antidepressant; panic and obsessive compulsive disorder, social phobia, eating disorders, psychosis |
| 01/31/2008 | US20080027069 Quinazoline compounds |
| 01/31/2008 | US20080027068 Heterocyclic compounds and thrombopoietin receptor activators |
| 01/31/2008 | US20080027067 Heterocyclic derivatives as modulators of ion channels |
| 01/31/2008 | US20080027066 Arylpiperazinyl Compounds |
| 01/31/2008 | US20080027065 G protein coupled receptor inhibitors (Gpr38) such as 6-[(4-fluorophenyl)oxy]-N-methyl-N-(4-{[(3S)-3-methyl-1-piperazinyl]methyl}phenyl)-3-pyridinecarboxamide for treatment of gastric stasis in an enterally fed patient |
| 01/31/2008 | US20080027058 Mitotic Kinesin Inhibitors |
| 01/31/2008 | US20080027053 Antimicrobial oxazolidinone prodrugs |
| 01/31/2008 | US20080027047 Compounds that modulate HSP90 activity and methods for identifying same |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080027037 Cyclic compounds |
| 01/31/2008 | US20080027035 Dpp-Iv Inhibitors |
| 01/31/2008 | US20080026407 Covalent tethering of functional groups to proteins |
| 01/31/2008 | US20080025919 Benzoylguanidine salt and hydrates thereof |
| 01/31/2008 | US20080025904 non-covalently linked complex comprising a high-order fullerene and two units of 2,7,12-Tris{N-[(amino-ethoxy)carbonyl]-6-undecanylisocytosine}-3,8,13-trime-thoxy-10,15-dihydro-5H-tribenzo[a,d,g]cyclononene |
| 01/31/2008 | US20080023646 Photostabilisation of Fluorescent Dyes |
| 01/31/2008 | CA2659259A1 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | CA2659253A1 Modulators of chemokine receptor activity, crystalline forms and process |
| 01/31/2008 | CA2658913A1 Substituted aniline derivatives |
| 01/31/2008 | CA2658821A1 Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors |
| 01/31/2008 | CA2658534A1 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
| 01/31/2008 | CA2657200A1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881977A1 Histone deacetylase inhibitors |
| 01/30/2008 | EP1881976A1 Substituted amide derivatives as protein kinase inhibitors |
| 01/30/2008 | EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/30/2008 | EP1881966A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-trianzin-6-ones, and their use as fungicides |
| 01/30/2008 | EP1881965A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators |
| 01/30/2008 | CN101115803A Dye, ink, ink for inkjet, inkjet recording method, ink sheet, color toner, and color filter |
| 01/30/2008 | CN101115752A 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 01/30/2008 | CN101115742A Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 01/30/2008 | CN101115738A Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 01/30/2008 | CN101115736A Potassium channel modulating agents and their medical use |
| 01/30/2008 | CN101115727A Compounds useful for inhibiting chk1 |
| 01/30/2008 | CN101115718A N- (heteroaryl) -1h-indole-2-carb0xamide derivatives and their use as vanilloid TRPV1 receptor ligands |
| 01/30/2008 | CN101115715A Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 01/30/2008 | CN101115482A 杂环天冬氨酰蛋白酶抑制剂 Heterocyclic aspartyl protease inhibitors |
| 01/30/2008 | CN101113148A Dioxygen piperazidine compounds and preparation method and usage thereof |
| 01/30/2008 | CN100364991C Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof |
| 01/30/2008 | CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors |
| 01/29/2008 | US7323475 Adjust concentration of erythropoietin in blood; strokes; antiepileptic agents; liver disorders; antiulcer agents; central nervous system disorders |
| 01/29/2008 | US7323470 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 01/29/2008 | US7323465 Alkansulfonamides as endothelin antagonists |
| 01/29/2008 | US7323464 Kinase inhibitors; autoimmune disease; antiinflammatory agents |
| 01/29/2008 | CA2297417C Derivatives of acyl-piperazinyl-pyrimidines, their preparation and application as medicaments |
| 01/29/2008 | CA2255620C Novel anandamide amidase inhibitors as analgesic agents |
| 01/24/2008 | WO2008011611A2 Compounds and compositions as itpkb inhibitors |
| 01/24/2008 | WO2008011392A2 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 01/24/2008 | WO2008011176A2 Myosin light chain kinase inhibitor compounds, compositions and related methods of use |
| 01/24/2008 | WO2008010433A1 Bridged cyanine compounds and optical recording materials containing the same |
| 01/24/2008 | WO2008009963A2 Pyrimidine derivatives as modulators of parathyroid hormone receptors |
| 01/24/2008 | WO2008009734A1 Macrocyclic lactams |
| 01/24/2008 | WO2008009691A1 Pyrimidine derivatives and their use as pesticides |
| 01/24/2008 | WO2008009487A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 01/24/2008 | WO2008009406A1 Novel pyridazine derivatives |
| 01/24/2008 | WO2008009405A2 Novel pyridazine derivatives |
| 01/24/2008 | WO2008009215A1 Tetrahydro isoquinoline derivatives, preparation methods and medicinal uses thereof |
| 01/24/2008 | WO2008009210A1 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 01/24/2008 | WO2008009209A1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases |
| 01/24/2008 | WO2008009078A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| 01/24/2008 | WO2008009077A2 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives and pharmaceutical compositions useful for treating viral infections |
| 01/24/2008 | WO2007142905A3 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands |
| 01/24/2008 | WO2007137417B1 Heterocyclic compounds as calcium channel blockers |
| 01/24/2008 | WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 01/24/2008 | WO2007135131A8 Substituted pyrazinone derivatives for use as a medicine |
| 01/24/2008 | WO2007123953A3 Phosphodiesterase 4 inhibitors |
| 01/24/2008 | WO2007122156A9 2-substituted 4-benzylphthalazinone derivatives as histamine h1 and h3 antagonists |